147 related articles for article (PubMed ID: 508509)
1. The influence of food on the bioavailability of new formulations of erythromycin stearate and base.
Rutland J; Berend N; Marlin GE
Br J Clin Pharmacol; 1979 Oct; 8(4):343-7. PubMed ID: 508509
[TBL] [Abstract][Full Text] [Related]
2. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food.
Clayton D; Leslie A
J Int Med Res; 1981; 9(6):470-7. PubMed ID: 7319133
[TBL] [Abstract][Full Text] [Related]
3. Absorption of erythromycin stearate and enteric-coated erythromycin base after a single oral dose immediately before breakfast.
Schreiner A; Digranes A
Infection; 1984; 12(5):345-8. PubMed ID: 6511088
[TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin.
Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L; Josefsson K
Pharmacology; 1984; 29(6):305-11. PubMed ID: 6334320
[TBL] [Abstract][Full Text] [Related]
5. Influence of study design in assessing food effects on absorption of erythromycin base and erythromycin stearate.
DiSanto AR; Chodos DJ
Antimicrob Agents Chemother; 1981 Aug; 20(2):190-6. PubMed ID: 7283417
[TBL] [Abstract][Full Text] [Related]
6. Treatment of respiratory tract infections with erythromycin acistrate and two formulations of erythromycin base.
Wuolijoki E; Flygare U; Hildén M; Hurme J; Järvinen H; Leskinen J; Pynnönen S; Riikonen A; Salomaa V; Seuri M
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():107-12. PubMed ID: 3391872
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability and effect of food on the gastrointestinal absorption of two erythromycin derivatives.
Mäntylä R; Ailio A; Allonen H; Kanto J
Ann Clin Res; 1978 Oct; 10(5):258-62. PubMed ID: 367255
[TBL] [Abstract][Full Text] [Related]
8. Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base.
Josefsson K; Bergan T; Magni L
Br J Clin Pharmacol; 1982 May; 13(5):685-91. PubMed ID: 7082537
[TBL] [Abstract][Full Text] [Related]
9. [Bioavailability of formulations containing erythromycin base or stearate in soft enteric gelatin capsules].
Springolo V
Boll Chim Farm; 1978 Feb; 117(2):113-21. PubMed ID: 743360
[No Abstract] [Full Text] [Related]
10. Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets.
DiSanto AR; Tserng KY; Chodos DJ; DeSante KA; Albert KS; Wagner JG
J Clin Pharmacol; 1980 Jul; 20(7):437-43. PubMed ID: 7430412
[TBL] [Abstract][Full Text] [Related]
11. Effect of food on absorption and hydrolysis of erythromycin acistrate.
Järvinen A; Nykänen S; Mattila J; Haataja H
Arzneimittelforschung; 1992 Jan; 42(1):73-6. PubMed ID: 1586385
[TBL] [Abstract][Full Text] [Related]
12. Fate of single oral doses of erythromycin acistrate, erythromycin stearate and pelleted erythromycin base analysed by mass-spectrometry in plasma of healthy human volunteers.
Männistö PT; Taskinen J; Ottoila P; Solkinen A; Vuorela A; Nykänen S
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():33-43. PubMed ID: 3391874
[TBL] [Abstract][Full Text] [Related]
13. Plasma and saliva concentrations for a new formulation of erythromycin stearate.
Berend N; Rutland J; Marlin GE
Curr Med Res Opin; 1979; 6(2):118-23. PubMed ID: 467089
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of erythromycin stearate: influence of food and fluid volume.
Welling PG; Huang H; Hewitt PF; Lyons LL
J Pharm Sci; 1978 Jun; 67(6):764-6. PubMed ID: 660450
[TBL] [Abstract][Full Text] [Related]
15. Bioinequivalence of erythromycin ethylsuccinate and enteric-coated erythromycin pellets following multiple oral doses.
Yakatan GJ; Rasmussen CE; Feis PJ; Wallen S
J Clin Pharmacol; 1985; 25(1):36-42. PubMed ID: 3871797
[TBL] [Abstract][Full Text] [Related]
16. Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state.
Tuominen RK; Männistö PT; Pohto P; Solkinen A; Vuorela A
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():45-55. PubMed ID: 3391875
[TBL] [Abstract][Full Text] [Related]
17. Tonsillar penetration of erythromycin and its 2'-acetyl ester in patients with chronic tonsillitis.
Savolainen S; Männistö PT; Gordin A; Antikainen R; Haataja H; Tuominen RK; Ylikoski J
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():73-84. PubMed ID: 3391878
[TBL] [Abstract][Full Text] [Related]
18. Effect of food on absorption of erythromycin. A study of two derivatives, the stearate and the base.
Malmborg AS
J Antimicrob Chemother; 1979 Sep; 5(5):591-9. PubMed ID: 500517
[TBL] [Abstract][Full Text] [Related]
19. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
[TBL] [Abstract][Full Text] [Related]
20. Penetration of erythromycin into periapical lesions after repeated doses of erythromycin acistrate and erythromycin stearate: a pilot study.
Tuominen RK; Lehtinen R; Peltola J; Wikberg R; Gordin A; Kokkonen P; Pohto P
Oral Surg Oral Med Oral Pathol; 1991 Jun; 71(6):684-8. PubMed ID: 2062521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
